Close
  Indian J Med Microbiol
 

Figure 3: Representative examples of cross-sectional optical coherence tomography scans from eyes of diabetic macular edema with focal VMA+ (a), diffuse VMA+ (b) and VMA− (c) showing improved diabetic macular edema after IVI of ranibizumab and release of adhesion in focal VMA+. IVI: Intravitreal anti-VEGF injection, VMA: Vitreomacular adhesion, CST: Central subfield thickness

Figure 3: Representative examples of cross-sectional optical coherence tomography scans from eyes of diabetic macular edema with focal VMA+ (a), diffuse VMA+ (b) and VMA− (c) showing improved diabetic macular edema after IVI of ranibizumab and release of adhesion in focal VMA+. IVI: Intravitreal anti-VEGF injection, VMA: Vitreomacular adhesion, CST: Central subfield thickness